Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

MMP inhibitors under investigation at Pharmacia & Upjohn

Aug. 27, 1998

FDA gives priority review status to COX-2 inhibitor

Aug. 27, 1998

Selective MMP-3 inhibitor PS-508 described at ACS meeting

Aug. 26, 1998

ACS news flash: Rhone-Poulenc Rorer studies dual PDE4/MMP inhibitors

Aug. 26, 1998

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Aug. 26, 1998

FDA advisory committee meeting scheduled to review Enbrel BLA

Aug. 25, 1998

Mitsui Toatsu researches cell adhesion inhibitors for a range of potential indications

Aug. 21, 1998

Immune Response evaluates rheumatoid arthritis vaccine in follow-up trial

Aug. 21, 1998

Antiarthritic activity of cromoglicate lisetil in a model of immunologically-mediated disease

Aug. 20, 1998

Kotobuki also conducting research on COX-2 inhibitors

Aug. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...